GI Cancer Clinical Trials

8 recruitingLast updated: June 17, 2026

There are 8 actively recruiting gi cancer clinical trials across 4 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Bethesda, Maryland, United States, Boston, Massachusetts, United States, Long Island City, New York, United States. Updated daily from ClinicalTrials.gov.


GI Cancer Trials at a Glance

8 actively recruiting trials for gi cancer are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Bethesda, Boston, and Long Island City. Lead sponsors running gi cancer studies include Chang Gung Memorial Hospital, Mabwell (Shanghai) Bioscience Co., Ltd., and Avera McKennan Hospital & University Health Center.

Browse gi cancer trials by phase

Treatments under study

About GI Cancer Clinical Trials

Looking for clinical trials for GI Cancer? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new GI Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about GI Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

Gastrointestinal CancerCancer of Gastrointestinal TractNon-GI Cancers
National Cancer Institute (NCI)550 enrolled1 locationNCT01313442
Recruiting
Not Applicable

Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing

Breast CancerPancreatic CancerOvarian Cancer+4 more
Unity Health Toronto180 enrolled2 locationsNCT07387263
Recruiting
Phase 1Phase 2

First-in-human Study of 7MW4911 in GI Cancer

GI Cancers
Mabwell (Shanghai) Bioscience Co., Ltd.200 enrolled5 locationsNCT07216560
Recruiting
Not Applicable

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

Breast CancerProstate CancerHead and Neck Cancer+4 more
The New York Proton Center1,800 enrolled1 locationNCT05313191
Recruiting

Avera Cancer Sequencing and Analytics Protocol (ASAP)

Breast CancerOvarian CancerEndometrial Cancer+9 more
Avera McKennan Hospital & University Health Center25,000 enrolled6 locationsNCT05142033
Recruiting

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

Gastric CancerEsophageal NeoplasmsGastric Adenocarcinoma+6 more
Western Sydney Local Health District500 enrolled1 locationNCT05804331
Recruiting
Not Applicable

Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy

GI Cancer
Chang Gung Memorial Hospital138 enrolled1 locationNCT06040801
Recruiting

Genomics and Prognosis in GI Cancers

Liver CancerGI Cancer
National Health Research Institutes, Taiwan1,000 enrolled2 locationsNCT05767697